MR. NIELS SMEDEGAARD ANDERSEN
Osteopathic Medicine at Eastlake Ave, Seattle, WA
License number
Washington FE60122569
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
825 Eastlake Ave E, Seattle, WA 98109
Phone
(206) 288-6956
(206) 696-6229
(206) 696-6229
Personal information
See more information about NIELS SMEDEGAARD ANDERSEN at radaris.comName
Address
Phone
19538 67Th Ave NE, Bothell, WA 98028
1009 36Th St, Seattle, WA 98103
6529 Greenwood Ave, Seattle, WA 98103
1009 36Th St, Seattle, WA 98103
6556 Phinney Ave N, Seattle, WA 98103
Professional information
Professor Of Chemistry At University Of Washington
Position:
Professor of Chemistry at University of Washington
Location:
Greater Seattle Area
Industry:
Research
Work:
University of Washington
-
Professor of Chemistry
Niels S Andersen, Seattle WA
Specialties:
Hematology, Hematology & Oncology
Address:
825 Eastlake Ave E, Seattle 98109
(206) 288-6956 (Phone)
(206) 288-6956 (Phone)
Languages:
English
Antibacterial Agents
US Patent:
2007024, Oct 18, 2007
Filed:
May 3, 2006
Appl. No.:
11/417346
Inventors:
Niels Andersen - Seattle WA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 31/19, C07C 259/04
US Classification:
514575000, 562623000
Abstract:
Antibacterial compounds of formula I are provided:
As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
Antibacterial Agents
US Patent:
7358359, Apr 15, 2008
Filed:
Jul 22, 2005
Appl. No.:
11/187708
Inventors:
Niels H. Andersen - Seattle WA, US
Jason Bowman - Quincy IL, US
Jason Bowman - Quincy IL, US
Assignee:
University of Washington - Seattle WA
International Classification:
C07D 223/00, C07D 265/00, C07D 263/00, C07D 295/00, C07D 239/00, C07D 241/00, C07D 415/00
US Classification:
544165, 540610, 544312, 544330, 544400, 544410, 546133, 546169, 546190, 546224, 5462821, 546337, 548127, 5483097, 5483381, 5483751
Abstract:
Antibacterial compounds of formula I are provided:As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
Antibacterial Agents
US Patent:
8101640, Jan 24, 2012
Filed:
Oct 31, 2007
Appl. No.:
11/981279
Inventors:
Niels H. Andersen - Seattle WA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Emeryville CA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Emeryville CA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
University of Washington - Seattle WA
University of Washington - Seattle WA
International Classification:
A61K 31/44, C07D 213/56
US Classification:
514357, 546332
Abstract:
Antibacterial compounds of formula I are provided:As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
Antibacterial Agents
US Patent:
8084615, Dec 27, 2011
Filed:
Oct 30, 2007
Appl. No.:
11/928122
Inventors:
Niels H. Andersen - Seattle WA, US
Jason Bowman - Quincy IL, US
Alice L. Erwin - Somerville MA, US
Eric A. Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Phoenixville PA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Jason Bowman - Quincy IL, US
Alice L. Erwin - Somerville MA, US
Eric A. Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Phoenixville PA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Assignee:
University of Washington - Seattle WA
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
C07D 213/00, C07D 213/24, C07D 333/22, C07D 413/04, C07D 239/10, C07D 239/02, C07D 241/12, C07D 401/04, A61K 31/55, A61K 31/535, A61K 31/497, A61K 31/505, A61K 31/44, A61K 31/38, A61K 31/445
US Classification:
546309, 544131, 544311, 544332, 544336, 544360, 546208, 5462681, 546334, 546345, 549 77, 51421704, 5142355, 5142521, 51425301, 514256, 514272, 514318, 514352, 514357, 514438
Abstract:
Antibacterial compounds of formula I are provided:As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
Antibacterial Agents
US Patent:
2008026, Oct 30, 2008
Filed:
Aug 10, 2007
Appl. No.:
11/837327
Inventors:
Niels H. Andersen - Seattle WA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
Jason Bowman - Quincy IL, US
Alice Erwin - Seattle WA, US
Eric Harwood - Seattle WA, US
Toni Kline - Seattle WA, US
Simon Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Ribhi Shawar - Bellevue WA, US
Allan S. Wagman - Belmont CA, US
Asha Yabannavar - Lafayette CA, US
International Classification:
A61K 31/5375, C07C 233/04, A61K 31/166, C07D 207/09, A61P 43/00, A61K 31/4015, C07D 265/30
US Classification:
5142378, 564165, 514620, 548538, 514423, 544169
Abstract:
Antibacterial compounds of formula I are provided:As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.
Niels Smedegaard Andersen, Seattle WA
Specialties:
Hematologist
Address:
825 Eastlake Ave E, Seattle, WA 98109
Alkyl Diethers Of Prostaglandins
US Patent:
4055593, Oct 25, 1977
Filed:
Apr 23, 1975
Appl. No.:
5/570621
Inventors:
Ned M. Weinshenker - Sunnyvale CA
Niels H. Andersen - Seattle WA
Niels H. Andersen - Seattle WA
Assignee:
Alza Corporation - Palo Alto CA
International Classification:
C07C17700
US Classification:
260514D
Abstract:
Novel alkyl diethers of prostaglandins of the formula; ##STR1## wherein R. sub. 1 is hydrogen or lower alkyl; R. sub. 2 and R. sub. 6 are hydrogen when Y is a single bond and R. sub. 2 and R. sub. 6 are absent when Y is a double bond; R. sub. 3 is keto, ##STR2## R. sub. 4 is hydrogen or ##STR3## R'. sub. 9 is hydrogen or lower alkyl; R'. sub. 10 is lower alkyl; R'. sub. 11 is lower alkyl; Z. sub. 1 is cis or trans --CH. dbd. CH-- or --CH. sub. 2 CH. sub. 2 --; Z. sub. 2 is trans --CH. dbd. CH-- or --CH. sub. 2 CH. sub. 2 --; X is a single bond or a double bond and X is a single bond when R. sub. 4 and R. sub. 5 are hydrogen; Y is a single bond or a double bond; n is 1 to 5, m is 0 to 4; and the non-toxic salts. The prostaglandin ethers possess valuable pharmacological properties as modifiers of smooth muscle activity, gastric secretion, blood pressure, lipolysis and the reproductive system. The compounds also induce labor and menses and they can be used for the relief of asthma and nasal congestion.
Monomeric Phthalocyanine Reagents
US Patent:
5494793, Feb 27, 1996
Filed:
Jun 14, 1989
Appl. No.:
7/366971
Inventors:
Deborah C. Schindele - Seattle WA
Barry V. Pepich - Seattle WA
George E. Renzoni - Seattle WA
Karen L. Fearon - Woodinville WA
Niels H. Andersen - Seattle WA
Thomas H. Stanton - Seattle WA
Barry V. Pepich - Seattle WA
George E. Renzoni - Seattle WA
Karen L. Fearon - Woodinville WA
Niels H. Andersen - Seattle WA
Thomas H. Stanton - Seattle WA
Assignee:
British Technology Group USA Inc. - Gulph Mills PA
International Classification:
C12Q 168, G01N 3353, C12N 900, C07H 2104
US Classification:
435 6
Abstract:
Fluorescent and/or chromogenic reagents in which a phthalocyanine derivative is monomerically conjugated with an antigen, antibody, oligonucleotide, or nucleic acid. Methods are presented in in which greater than 90% of the phthalocyanine dyes are monomeric when conjugated. This greatly enhances their performance as detectable markers in immunoassays, nucleic acid probe assays, immunoblotting, hybridization assays, microscopy, imaging, flow cytometry, DNA sequencing, and photodynamic therapy. For use as fluorophores, the free base phthalocyanine may or may not be metallated. Metals for fluorescent phthalocyanine include aluminum, silicon, phosphorus, gallium, germanium, cadmium, scandium, magnesium, tin, and zinc. For use as chromogens, the phthalocyanine may or may not be metallated. For use in aqueous solution, the phthalocyanine macrocycle should be derivatized with water-solubilizing substituents such as sulfonic acid, phosphate, phosphonate, hydroxy, phenoxy, amino, ammonium, or pyridinium groups.